Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAIL: a potential agent for cancer therapy.

Juan Shi1, Dexian Zheng, Kwan Man

  • 1Gene Therapy Laboratory, IMB, The University of Hong Kong, Hong Kong.

Current Molecular Medicine
|December 20, 2003
PubMed
Summary

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise in cancer therapy by selectively inducing cancer cell death. Combining TRAIL with chemotherapy or radiation enhances its effectiveness, though potential cytotoxicity requires further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.

Journal of nanobiotechnology·2026
Same author

Association of GLP-1RA discontinuation and risk of depressive and anxiety disorders in people with type 2 diabetes: a cohort study.

Nature metabolism·2026
Same author

Mechanism of organic-driven homogeneous nucleation transition for Ca-organics co-removal in oil drilling wastewater reclamation.

Water research·2026
Same author

Tissue-specific changes in endophytic bacterial and fungal communities of two pine species associated with pine wilt disease.

Frontiers in microbiology·2026
Same author

Leaf Age-Dependent Volatile Cues Influence Host Location and Oviposition Preference of <i>Obolodiplosis robiniae</i> on <i>Robinia pseudoacacia</i>.

Insects·2026
Same author

How does AI literacy empower decision-making quality? The mediating role of employee-AI collaboration and the moderating role of AI trust.

Acta psychologica·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Conventional cancer therapies like chemotherapy and radiation often face challenges due to innate or acquired resistance in cancer cells.
  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo-2L) is a key molecule in the TNF ligand family, inducing programmed cell death (apoptosis) via death receptor activation.
  • TRAIL demonstrates therapeutic potential as most cancer cells are sensitive to its apoptotic effects, while normal cells exhibit resistance.

Purpose of the Study:

  • To review the regulatory mechanisms of TRAIL-induced apoptosis.
  • To elucidate the molecular basis for synergistic effects when TRAIL is combined with chemotherapy or irradiation.
  • To analyze the potential cytotoxicity of TRAIL as a limiting factor for its clinical application.

Main Methods:

Related Experiment Videos

  • This review synthesizes existing research on TRAIL-induced apoptosis.
  • It examines the molecular pathways involved in TRAIL signaling and cancer cell death.
  • The review analyzes studies investigating TRAIL in combination therapies and its safety profile.

Main Results:

  • TRAIL effectively induces apoptosis in a majority of cancer cell types.
  • Combining TRAIL with chemotherapy or radiation significantly enhances apoptotic outcomes.
  • Potential dose-limiting cytotoxicity of TRAIL is a critical consideration for therapeutic development.

Conclusions:

  • TRAIL represents a promising therapeutic agent for cancer treatment due to its selective induction of apoptosis in malignant cells.
  • Combination strategies involving TRAIL with conventional treatments amplify its anti-cancer efficacy.
  • Further research is necessary to optimize TRAIL-based therapies and mitigate potential adverse effects for successful clinical translation.